Lipoprotein‐Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

Journal of the American Heart Association

  ^{1    2    3    4    4    4    5    6    7    8    9    9    1,10    1,11    1,12    1,12    1,13    1,14    1,15} 

[1] Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada;Cardiovascular Division, Brigham and Women's Hospital, Boston, MA;Harvard Clinical Research Institute, Boston, MA;Department of Internal Medicine II‐Cardiology, University of Ulm Medical Center, Ulm, Germany;Deutsches Herzzentrum München, Technische Universität München, Munich, Germany;DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany;Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden;Uppsala Clinical Research Center (UCR), Uppsala University, Uppsala, Sweden;Department of Medicine, NYU Langone Medical Center, New York, NY;Department of Medicine, Stanford University, Stanford, CA;FACT (French Alliance for Cardiovascular Trials), Paris, France;DHU FIRE, Université Paris‐Diderot, Sorbonne Paris‐Cité, Paris, France;Hôpital Bichat, INSERUM U‐1148, Paris, France;NHLI, ICMS, Imperial College, Royal Brompton Hospital, London, UK;Former Employee of Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, King of Prussia, PA;Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand;University of Auckland, New Zealand;Maine Research Associates, Auburn, ME;Medical Center, Duke University, Durham, NC;Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, King of Prussia, PA;Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;Uppsala Clinical Research Center (UCR), Uppsala University, Uppsala, Sweden;Uppsala Clinical Research Center (UCR), Uppsala University, Uppsala, Sweden;Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden;

关键词: atherosclerosis;    coronary disease;    inflammation;    lipoprotein;    myocardial infarction;   

DOI  :  10.1161/JAHA.116.003407

来源: publisher

【 授权许可】

Unknown